Does Rallies show Form 4 insider transactions for WGS?

Yes. Rallies tracks WGS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is WGS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WGS. It does not provide personalized investment advice.

WGS (GeneDx Holdings Corp. Class A Common Stock) Stock Analysis - Insider Trades

GeneDx Holdings Corp. Class A Common Stock (WGS) is a publicly traded Healthcare sector company. As of May 20, 2026, WGS trades at $44.09 with a market cap of $1.27B and a P/E ratio of -59.93. WGS moved +6.22% today. Year to date, WGS is -65.98%; over the trailing twelve months it is -37.97%. Its 52-week range spans $32.21 to $170.87. Analyst consensus is strong buy with an average price target of $91.25. Rallies surfaces WGS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading WGS stock inside the company?

Recent WGS insider activity includes Meister Keith A. bought 27.41K, Meister Keith A. bought 18.86K, Meister Keith A. bought 88.11K, Meister Keith A. bought 51.89K, and Meister Keith A. bought 94.07K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

WGS Key Metrics

Key financial metrics for WGS
Metric	Value
Price	$44.09
Market Cap	$1.27B
P/E Ratio	-59.93
EPS	$-0.73
Dividend Yield	0.00%
52-Week High	$170.87
52-Week Low	$32.21
Volume	999.66K
Avg Volume	0
Revenue (TTM)	$427.54M
Net Income	$-21.02M
Gross Margin	69.74%

Recent WGS Insider Trades

Meister Keith A. bought 27.41K (~$1.05M) on May 15, 2026.
Meister Keith A. bought 18.86K (~$751.39K) on May 15, 2026.
Meister Keith A. bought 88.11K (~$3.44M) on May 14, 2026.
Meister Keith A. bought 51.89K (~$2.07M) on May 14, 2026.
Meister Keith A. bought 94.07K (~$3.65M) on May 13, 2026.

Latest WGS News

GeneDx Cuts 2026 Revenue Outlook to $475–490M After 34% Volume Surge — May 4, 2026
GeneDx Forecasts Q1 $113M Revenue and Deepens 2026 Loss Forecast to $1.38 EPS — May 1, 2026
GeneDx Expands NPC Testing Access with Zevra via ExomeDx and Infinity Dataset — Mar 10, 2026
Analysts’ $156.67 Mean Target Implies 77.8% Upside for GeneDx — Mar 9, 2026
GeneDx Holdings Falls 25% in Four Weeks While EPS Estimates Rise 29.3% — Mar 3, 2026

WGS Analyst Consensus

8 analysts cover WGS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.25.

Common questions about WGS

Who is trading WGS stock inside the company?: Recent WGS insider activity includes Meister Keith A. bought 27.41K, Meister Keith A. bought 18.86K, Meister Keith A. bought 88.11K, Meister Keith A. bought 51.89K, and Meister Keith A. bought 94.07K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for WGS?: Yes. Rallies tracks WGS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is WGS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WGS. It does not provide personalized investment advice.